Free Trial

Gemini Therapeutics (GMTX) News Today

Gemini Therapeutics logo
$67.64 +0.73 (+1.09%)
As of 05/4/2026

GMTX Latest News

Gemini Horoscope
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates GMTX, RMED, LOTZ
SHAREHOLDER NOTICE: Halper Sadeh LLP Investigates BHVN, DRE, PLD, GMTX, SAFE
Gemini Therapeutics (Nasdaq:GMTX) Headline
Trading was temporarily halted for "GMTX" at 07:08 AM with a stated reason of "News pending."...
Gemini Therapeutics GAAP EPS of -$1.78 beats by $0.17
Gemini Therapeutics Reports 2021 Financial Results
Two more Cambridge biotechs cutting staff
Gemini Therapeutics names interim CEO, announces job cuts
Gemini Therapeutics Provides Corporate Update
Gemini Therapeutics, Inc. Common Stock (GMTX)
Gemini Therapeutics Provides GEM103 Program Update
Gemini Therapeutics Shares Jump As HC Wainwright Sees Over 500% Upside
Gemini Therapeutics Announces Poster Presentation at AAO 2021
Get Gemini Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for GMTX and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

GMTX Media Mentions By Week

GMTX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

GMTX
News Sentiment

0.00

0.59

Average
Medical
News Sentiment

GMTX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

GMTX Articles
This Week

1

0

GMTX Articles
Average Week

Get the Latest News and Ratings for GMTX and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Gemini Therapeutics and its competitors.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools


This page (NASDAQ:GMTX) was last updated on 5/5/2026 by MarketBeat.com Staff.
From Our Partners